Hologic

@Hologic

We're an innovative medical technology company w/ a passion for #womenshealth that drives us to enable healthier lives everywhere, every day.

Marlborough, MA

Joined April 2009

Hologic
@Hologic
Aug 17
Aptima® HPV Assay, powered by mRNA technology, improves specificity, with 24-40% fewer false positives than DNA-based tests. Dr. Kyle Bukowski explains how this can reduce repeat visits, support targeted care and lower reliance on colposcopy. Watch: ow.ly/g79h50ZiKZG
Hologic
@Hologic
Jul 27
Aptima® HPV Assay uses mRNA-based technology to identify active high-risk infections most likely to progress to disease. This can support clinical specificity and help avoid unnecessary follow-up and procedures. Watch the webinar: ow.ly/r8Yc50ZiKSH #CervicalHealth
00:00
Hologic
@Hologic
Jul 7
Identifying high-risk HPV infections starts with the right test. Dr. Kyle Bukowski, Hologic’s Medical Director, explains how the Aptima® HPV Assay targets E6/E7 mRNA focusing on genotypes 16, 18 & 45—linked to up to 92% of cervical adenocarcinomas. Watch: ow.ly/Zxce50ZiKNl
00:00
Hologic
@Hologic
Jun 1
Expedited partner therapy is helping close gaps in STI care, making it easier to treat partners and reduce reinfection. How is it being adopted, and what barriers remain? Learn more from Dr. Tonya Chaffee*: ow.ly/K4uA50Z1Hjt #SexualHealth *Paid consultant for Hologic.
Hologic
@Hologic
May 20
Closing gaps in the STI Continuum of Care starts with stronger partnerships. Dr. Melissa Martinez-Adorno* shares how lab-provider collaboration can help better protect #SexualHealth in @captodayonline: captodaymag.com/captoday/libra… *Paid Hologic consultant.